Overview
- The U.S. Department of Justice is investigating UnitedHealth Group for potential Medicare fraud in its Medicare Advantage program, overseen by the DOJ’s healthcare fraud unit.
- UnitedHealth's stock dropped 6–8% in after-hours trading on May 14, extending a nearly 50% decline over the past month.
- The company claims it has not been notified of the investigation and maintains confidence in the integrity of its Medicare Advantage practices.
- This development follows the abrupt resignation of CEO Andrew Witty, with former CEO Stephen Hemsley returning to lead the company through ongoing crises.
- UnitedHealth is also contending with other legal challenges, including civil fraud and antitrust probes, as well as shareholder lawsuits tied to the fallout from the 2024 murder of a top executive.